Form4insider filings, from the source

SEC Form 4 · accession 0001209191-15-035491

Cidara Therapeutics, Inc. · CDTX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Apr 20, 2015
Accepted (ET)
Apr 22, 2015 · 2:49 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001610618

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Apr 20, 2015P155,645$16.00A155,645IBy limited partnership
Common StockF2,F1Apr 20, 2015C865,590—A1,021,235IBy limited partnership
Common StockF3Apr 20, 2015P44,355$16.00A44,355IBy limited partnership
Common StockF2,F3Apr 20, 2015C246,668—A291,023IBy limited partnership

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Convertible Preferred StockF1,F2—Apr 20, 2015C865,590D——Common Stock865,5900I
Convertible Preferred StockF3,F2—Apr 20, 2015C246,668D——Common Stock246,6680I

Explanation of responses